Login
Home
Charts
Search
Watchlist
Products

Skybiotech Healthcare Limited

SKYBIOTECH·BSE
₹115.050.00%Wed, 23 Sept '26 15:07
Industry:Textiles - Processing
Indices:

Skybiotech Healthcare Limited

SKYBIOTECH
BSE
₹115.05
0.00%
|Wed, 23 Sept '26 15:07
SOICxStockScans Reports
Industry
Textiles - Processing
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹22Cr
Close
Close Price
₹115.05
Industry
Industry
Textiles - Processing
PE
Price To Earnings
—
PS
Price To Sales
4.24
Revenue
Revenue
₹5Cr
Rev Gr TTM
Revenue Growth TTM
-30.94%
PAT Gr TTM
PAT Growth TTM
4.60%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
0023122120
Growth YoY
Revenue Growth YoY%
20.0-61.979.4-79.5
Expenses
ExpensesCr
0023222131
Operating Profit
Operating ProfitCr
0000-1000-1-1
OPM
OPM%
1.9-12.7-105.93.4-11.5-45.8-48.1-106.1
Other Income
Other IncomeCr
1000000000
Interest Expense
Interest ExpenseCr
0000000000
Depreciation
DepreciationCr
0000000000
PBT
PBTCr
1000-1000-1-1
Tax
TaxCr
00000000-10
PAT
PATCr
1000-10000-1
Growth YoY
PAT Growth YoY%
-136.4-108.0-24.0-23.172.2-2,750.0
NPM
NPM%
-15.6-15.5-105.9-0.8-16.1-50.0-16.4-116.3
EPS
EPS₹
7.11.85.5-3.1-13.70.3-1.3-1.3-3.0-2.6
QuarterDec 2023Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
0023122120
Growth YoY
Revenue Growth YoY%
20.0-61.979.4-79.5
Expenses
ExpensesCr
0023222131
Operating Profit
Operating ProfitCr
0000-1000-1-1
OPM
OPM%
1.9-12.7-105.93.4-11.5-45.8-48.1-106.1
Other Income
Other IncomeCr
1000000000
Interest Expense
Interest ExpenseCr
0000000000
Depreciation
DepreciationCr
0000000000
PBT
PBTCr
1000-1000-1-1
Tax
TaxCr
00000000-10
PAT
PATCr
1000-10000-1
Growth YoY
PAT Growth YoY%
-136.4-108.0-24.0-23.172.2-2,750.0
NPM
NPM%
-15.6-15.5-105.9-0.8-16.1-50.0-16.4-116.3
EPS
EPS₹
7.11.85.5-3.1-13.70.3-1.3-1.3-3.0-2.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
0775
Growth
Revenue Growth%
0.7-30.9
Expenses
ExpensesCr
0997
Operating Profit
Operating ProfitCr
0-2-1-2
OPM
OPM%
-32.0-20.7-39.6
Other Income
Other IncomeCr
2000
Interest Expense
Interest ExpenseCr
0000
Depreciation
DepreciationCr
0100
PBT
PBTCr
2-2-2-2
Tax
TaxCr
00-1-1
PAT
PATCr
2-2-1-2
Growth
PAT Growth%
-253.852.74.6
NPM
NPM%
-33.6-15.8-31.9
EPS
EPS₹
3.7-14.2-6.7-8.1
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
0775
Growth
Revenue Growth%
0.7-30.9
Expenses
ExpensesCr
0997
Operating Profit
Operating ProfitCr
0-2-1-2
OPM
OPM%
-32.0-20.7-39.6
Other Income
Other IncomeCr
2000
Interest Expense
Interest ExpenseCr
0000
Depreciation
DepreciationCr
0100
PBT
PBTCr
2-2-2-2
Tax
TaxCr
00-1-1
PAT
PATCr
2-2-1-2
Growth
PAT Growth%
-253.852.74.6
NPM
NPM%
-33.6-15.8-31.9
EPS
EPS₹
3.7-14.2-6.7-8.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026
Equity Capital
Equity CapitalCr
22
Reserves
ReservesCr
76
Current Liabilities
Current LiabilitiesCr
32
Non Current Liabilities
Non Current LiabilitiesCr
78
Total Liabilities
Total LiabilitiesCr
2019
Current Assets
Current AssetsCr
21
Non Current Assets
Non Current AssetsCr
1818
Total Assets
Total AssetsCr
2019
Financial YearMar 2025Mar 2026
Equity Capital
Equity CapitalCr
22
Reserves
ReservesCr
76
Current Liabilities
Current LiabilitiesCr
32
Non Current Liabilities
Non Current LiabilitiesCr
78
Total Liabilities
Total LiabilitiesCr
2019
Current Assets
Current AssetsCr
21
Non Current Assets
Non Current AssetsCr
1818
Total Assets
Total AssetsCr
2019

Cash Flow

Consolidated
Standalone
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-1-2
Investing Cash Flow
Investing Cash FlowCr
-100
Financing Cash Flow
Financing Cash FlowCr
11
Net Cash Flow
Net Cash FlowCr
-90
Free Cash Flow
Free Cash FlowCr
-1
CFO To PAT
CFO To PAT%
44.0135.7
CFO To EBITDA
CFO To EBITDA%
46.2103.4
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-1-2
Investing Cash Flow
Investing Cash FlowCr
-100
Financing Cash Flow
Financing Cash FlowCr
11
Net Cash Flow
Net Cash FlowCr
-90
Free Cash Flow
Free Cash FlowCr
-1
CFO To PAT
CFO To PAT%
44.0135.7
CFO To EBITDA
CFO To EBITDA%
46.2103.4

Ratios

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
312922
Price To Earnings
Price To Earnings
-26.3
Price To Sales
Price To Sales
4.44.24.2
Price To Book
Price To Book
3.53.72.8
EV To EBITDA
EV To EBITDA
-17.2-26.2-15.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.9
OPM
OPM%
-32.0-20.7-39.6
NPM
NPM%
-33.6-15.8-31.9
ROCE
ROCE%
-14.9-10.1-10.1
ROE
ROE%
-26.4-14.0-14.0
ROA
ROA%
-11.8-5.8-5.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
312922
Price To Earnings
Price To Earnings
-26.3
Price To Sales
Price To Sales
4.44.24.2
Price To Book
Price To Book
3.53.72.8
EV To EBITDA
EV To EBITDA
-17.2-26.2-15.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.9
OPM
OPM%
-32.0-20.7-39.6
NPM
NPM%
-33.6-15.8-31.9
ROCE
ROCE%
-14.9-10.1-10.1
ROE
ROE%
-26.4-14.0-14.0
ROA
ROA%
-11.8-5.8-5.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Skybiotech Healthcare Limited

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/8b6ebsgfwivnrt2fx3g5xxkp.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/xu1n8jzuy6w3bh0zvrd75oh8.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/lwycf1a4sm7gl9ne3ftzas1y.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/ql47t79zoqxuskkvka76rfdi.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/fbo0vjjnnv8mbaytvora2u64.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/3nxky8a6irfxz81o53350r40.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/jn8zbkb2laat8q6lnuzz6ykt.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/e0wtldnvxo4535c04jz21n4z.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/md1oxxt06vxs7jwdkdsjqi71.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/fs5p7vw41obor7hlnqlvul1z.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/1elc5xktn2r2xepja6zxbl2t.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/x6rxgw0fmzytbx2qkvxuae0k.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/b6zqbi7zkltv59s35q7b7ffd.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/sthz2isidgsu8h7ty476bey7.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/fi77q1mrqy9jy9ltatp5q9y6.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies